EligibleTrials

Surveillance of Pancreatic Health After Diabetes Diagnosis

Recruiting · NCT06803771 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Southampton NHS Foundation Trust

View the official record on ClinicalTrials.gov →
Pancreatic cancerType 2 diabetes

Interventions studied

Avantect Pancreatic Cancer Test

What this trial is about

The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2 diabetes within the last 6 months. Participants will: * attend 3 study visits over 12 months time * provide a blood sample at each study visit * complete an anxiety questionnaire at each visit.

Who can take part

Age range
50 Years to 84 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

31 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.